Market Estimates
Valuation Metrics
Financials
Trading Trends
VRTX News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Vertex Pharmaceuticals Inc (VRTX) stock price today?
The current price of VRTX is 469.68 USD — it has decreased -2.99 % in the last trading day.
What is Vertex Pharmaceuticals Inc (VRTX)'s business?
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases, with a focus on specialty markets. It has seven approved medicines: five that treat the underlying cause of cystic fibrosis (CF), one that treats severe sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT), and one that treats moderate-to-severe acute pain. Its pipeline includes clinical-stage programs in CF, SCD, beta thalassemia, acute and peripheral neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy and other autoimmune renal diseases and cytopenias, type 1 diabetes, myotonic dystrophy type 1, and autosomal dominant polycystic kidney disease. Its marketed medicines are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (elexacaftor/tezacaftor/ivacaftor and ivacaftor), ORKAMBI (lumacaftor/ivacaftor), and KALYDECO (ivacaftor).
What is the price predicton of VRTX Stock?
Wall Street analysts forecast VRTX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VRTX is 482.53 USD with a low forecast of 401.00 USD and a high forecast of 575.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Vertex Pharmaceuticals Inc (VRTX)'s revenue for the last quarter?
Vertex Pharmaceuticals Inc revenue for the last quarter amounts to 3.08B USD, increased 10.99 % YoY.
What is Vertex Pharmaceuticals Inc (VRTX)'s earnings per share (EPS) for the last quarter?
Vertex Pharmaceuticals Inc. EPS for the last quarter amounts to 4.20 USD, increased 4.74 % YoY.
What changes have occurred in the market's expectations for Vertex Pharmaceuticals Inc (VRTX)'s fundamentals?
How many employees does Vertex Pharmaceuticals Inc (VRTX). have?
Vertex Pharmaceuticals Inc (VRTX) has 6100 emplpoyees as of January 09 2026.
What is Vertex Pharmaceuticals Inc (VRTX) market cap?
Today VRTX has the market capitalization of 119.17B USD.



![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260107230325_c519443db690b7166914c902c9f0de52.jpg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260106100648_9f8383fb9d4e0dc005f6303938f1416c.jpeg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fdefault_image%2Fnewsfilter.png&w=384&q=75)